lobeglitazone trade name duvie chong kun dang antidiabetic drug thiazolidinedione class drugs agonist pparα pparγ works insulin sensitizer binding ppar receptors fat cells making cells responsive lobeglitazone used assist regulation blood glucose level diabetes mellitus type patients used alone combination lobeglitazone approved ministry food drug safety korea postmarketing surveillance progress update absolute bioavailability lobeglitazone human mean steady state clearance clssf lh across mg dose range dose range mean halflife urine excretion negligible amount elimination lobeglitazone rat plasma protein binding drug average bloodtoplasma concentration ratio unbound fraction lobeglitazone microsomal incubation medium lobeglitazone primarily distributed liver tissuetoplasma concentration ratio less heart lung fat tissue plasma concentration ratios ranged major tissues among six major membrane transporters recommended united states food drug administration lobeglitazone interacts vitro lobeglitazone substrate rodent lobeglitazone interacted distribution liver lobeglitazone inhibited atorvastatin httpsenwikipediaorgwikilobeglitazone